ロード中...
BET bromodomains as novel epigenetic targets for brain health and disease
Epigenetic pharmacotherapy for CNS-related diseases is a burgeoning area of research. In particular, members of the bromodomain and extra-terminal domain (BET) family of proteins have emerged as intriguing therapeutic targets due to their putative involvement in an array of brain diseases. With thei...
保存先:
| 出版年: | Neuropharmacology |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7655633/ https://ncbi.nlm.nih.gov/pubmed/32946883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2020.108306 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|